Muscle function, linear growth, and bone health during 30 months of vamorolone, prednisone, and deflazacort treatment for Duchenne muscular dystrophy: a comparative study.

Ward LM, Jackowski S, Dang UJ, B Comm MS, Jaremko JL, Koujok K, Matzinger MA, Shenouda N, McMillan HJ, Siminoski K, Leinonen M, Rooman R, Hasham S, Clemens PR, Guglieri M, Hoffman EP

Open source

DOI: 10.1093/jbmr/zjag154
Published: 2026 Oct 29
Container: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/jbmr/zjag154,
  title = {Muscle function, linear growth, and bone health during 30 months of vamorolone, prednisone, and deflazacort treatment for Duchenne muscular dystrophy: a comparative study.},
  author = {Ward LM and Jackowski S and Dang UJ and B Comm MS and Jaremko JL and Koujok K and Matzinger MA and Shenouda N and McMillan HJ and Siminoski K and Leinonen M and Rooman R and Hasham S and Clemens PR and Guglieri M and Hoffman EP},
  year = {2026},
  journal = {Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research},
  doi = {10.1093/jbmr/zjag154},
  url = {https://doi.org/10.1093/jbmr/zjag154}
}

RIS

TY  - JOUR
TI  - Muscle function, linear growth, and bone health during 30 months of vamorolone, prednisone, and deflazacort treatment for Duchenne muscular dystrophy: a comparative study.
AU  - Ward LM
AU  - Jackowski S
AU  - Dang UJ
AU  - B Comm MS
AU  - Jaremko JL
AU  - Koujok K
AU  - Matzinger MA
AU  - Shenouda N
AU  - McMillan HJ
AU  - Siminoski K
AU  - Leinonen M
AU  - Rooman R
AU  - Hasham S
AU  - Clemens PR
AU  - Guglieri M
AU  - Hoffman EP
PY  - 2026
JO  - Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
DO  - 10.1093/jbmr/zjag154
UR  - https://doi.org/10.1093/jbmr/zjag154
ER  -

APA

LM, W., S, J., UJ, D., MS, B. C., JL, J., K, K., MA, M., N, S., HJ, M., K, S., M, L., R, R., S, H., PR, C., M, G., & EP, H. (2026). Muscle function, linear growth, and bone health during 30 months of vamorolone, prednisone, and deflazacort treatment for Duchenne muscular dystrophy: a comparative study.. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. https://doi.org/10.1093/jbmr/zjag154

Source records

pubmed · retrieved 2026-11-10T20:41:29.133Z